Global Proteomic Biomarker Market Research Report 2023

December 2023 | 107 pages | ID: G6BECADD0229EN
QYResearch

Abstracts

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Proteomic Biomarker market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Abbott Laboratories
• Agilent/Dako
• Amprion
• BasePair Biotechnologies
• Beckman Coulter Diagnostics
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Bruker
• C2N Diagnostics
• Cepheid (Danaher)
• Diadem Diagnostics
• Eve Technologies
• Fluidic Analytics
• Fujirebio
• Hybrigenics Services
• Luminex Corp (DiaSorin)
• NanoDx
• Nautilus Biotechnology
• Nicoya
• Olink
• Qiagen

Segment by Type

• Mass spectrometry
• Chromatography
• Blotting
• Others

Segment by Application

• Bio Industry
• Medical Industry
• Others

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Proteomic Biomarker report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Proteomic Biomarker Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Mass spectrometry
  1.2.3 Chromatography
  1.2.4 Blotting
  1.2.5 Others
1.3 Market by Application
  1.3.1 Global Proteomic Biomarker Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Bio Industry
  1.3.3 Medical Industry
  1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Proteomic Biomarker Market Perspective (2018-2029)
2.2 Proteomic Biomarker Growth Trends by Region
  2.2.1 Global Proteomic Biomarker Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Proteomic Biomarker Historic Market Size by Region (2018-2023)
  2.2.3 Proteomic Biomarker Forecasted Market Size by Region (2024-2029)
2.3 Proteomic Biomarker Market Dynamics
  2.3.1 Proteomic Biomarker Industry Trends
  2.3.2 Proteomic Biomarker Market Drivers
  2.3.3 Proteomic Biomarker Market Challenges
  2.3.4 Proteomic Biomarker Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Proteomic Biomarker Players by Revenue
  3.1.1 Global Top Proteomic Biomarker Players by Revenue (2018-2023)
  3.1.2 Global Proteomic Biomarker Revenue Market Share by Players (2018-2023)
3.2 Global Proteomic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Proteomic Biomarker Revenue
3.4 Global Proteomic Biomarker Market Concentration Ratio
  3.4.1 Global Proteomic Biomarker Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Proteomic Biomarker Revenue in 2022
3.5 Proteomic Biomarker Key Players Head office and Area Served
3.6 Key Players Proteomic Biomarker Product Solution and Service
3.7 Date of Enter into Proteomic Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PROTEOMIC BIOMARKER BREAKDOWN DATA BY TYPE

4.1 Global Proteomic Biomarker Historic Market Size by Type (2018-2023)
4.2 Global Proteomic Biomarker Forecasted Market Size by Type (2024-2029)

5 PROTEOMIC BIOMARKER BREAKDOWN DATA BY APPLICATION

5.1 Global Proteomic Biomarker Historic Market Size by Application (2018-2023)
5.2 Global Proteomic Biomarker Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Proteomic Biomarker Market Size (2018-2029)
6.2 North America Proteomic Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Proteomic Biomarker Market Size by Country (2018-2023)
6.4 North America Proteomic Biomarker Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Proteomic Biomarker Market Size (2018-2029)
7.2 Europe Proteomic Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Proteomic Biomarker Market Size by Country (2018-2023)
7.4 Europe Proteomic Biomarker Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Proteomic Biomarker Market Size (2018-2029)
8.2 Asia-Pacific Proteomic Biomarker Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Proteomic Biomarker Market Size by Region (2018-2023)
8.4 Asia-Pacific Proteomic Biomarker Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Proteomic Biomarker Market Size (2018-2029)
9.2 Latin America Proteomic Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Proteomic Biomarker Market Size by Country (2018-2023)
9.4 Latin America Proteomic Biomarker Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Proteomic Biomarker Market Size (2018-2029)
10.2 Middle East & Africa Proteomic Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Proteomic Biomarker Market Size by Country (2018-2023)
10.4 Middle East & Africa Proteomic Biomarker Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Detail
  11.1.2 Abbott Laboratories Business Overview
  11.1.3 Abbott Laboratories Proteomic Biomarker Introduction
  11.1.4 Abbott Laboratories Revenue in Proteomic Biomarker Business (2018-2023)
  11.1.5 Abbott Laboratories Recent Development
11.2 Agilent/Dako
  11.2.1 Agilent/Dako Company Detail
  11.2.2 Agilent/Dako Business Overview
  11.2.3 Agilent/Dako Proteomic Biomarker Introduction
  11.2.4 Agilent/Dako Revenue in Proteomic Biomarker Business (2018-2023)
  11.2.5 Agilent/Dako Recent Development
11.3 Amprion
  11.3.1 Amprion Company Detail
  11.3.2 Amprion Business Overview
  11.3.3 Amprion Proteomic Biomarker Introduction
  11.3.4 Amprion Revenue in Proteomic Biomarker Business (2018-2023)
  11.3.5 Amprion Recent Development
11.4 BasePair Biotechnologies
  11.4.1 BasePair Biotechnologies Company Detail
  11.4.2 BasePair Biotechnologies Business Overview
  11.4.3 BasePair Biotechnologies Proteomic Biomarker Introduction
  11.4.4 BasePair Biotechnologies Revenue in Proteomic Biomarker Business (2018-2023)
  11.4.5 BasePair Biotechnologies Recent Development
11.5 Beckman Coulter Diagnostics
  11.5.1 Beckman Coulter Diagnostics Company Detail
  11.5.2 Beckman Coulter Diagnostics Business Overview
  11.5.3 Beckman Coulter Diagnostics Proteomic Biomarker Introduction
  11.5.4 Beckman Coulter Diagnostics Revenue in Proteomic Biomarker Business (2018-2023)
  11.5.5 Beckman Coulter Diagnostics Recent Development
11.6 Becton, Dickinson and Company
  11.6.1 Becton, Dickinson and Company Company Detail
  11.6.2 Becton, Dickinson and Company Business Overview
  11.6.3 Becton, Dickinson and Company Proteomic Biomarker Introduction
  11.6.4 Becton, Dickinson and Company Revenue in Proteomic Biomarker Business (2018-2023)
  11.6.5 Becton, Dickinson and Company Recent Development
11.7 Bio-Rad Laboratories, Inc.
  11.7.1 Bio-Rad Laboratories, Inc. Company Detail
  11.7.2 Bio-Rad Laboratories, Inc. Business Overview
  11.7.3 Bio-Rad Laboratories, Inc. Proteomic Biomarker Introduction
  11.7.4 Bio-Rad Laboratories, Inc. Revenue in Proteomic Biomarker Business (2018-2023)
  11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Bio-Techne
  11.8.1 Bio-Techne Company Detail
  11.8.2 Bio-Techne Business Overview
  11.8.3 Bio-Techne Proteomic Biomarker Introduction
  11.8.4 Bio-Techne Revenue in Proteomic Biomarker Business (2018-2023)
  11.8.5 Bio-Techne Recent Development
11.9 Bruker
  11.9.1 Bruker Company Detail
  11.9.2 Bruker Business Overview
  11.9.3 Bruker Proteomic Biomarker Introduction
  11.9.4 Bruker Revenue in Proteomic Biomarker Business (2018-2023)
  11.9.5 Bruker Recent Development
11.10 C2N Diagnostics
  11.10.1 C2N Diagnostics Company Detail
  11.10.2 C2N Diagnostics Business Overview
  11.10.3 C2N Diagnostics Proteomic Biomarker Introduction
  11.10.4 C2N Diagnostics Revenue in Proteomic Biomarker Business (2018-2023)
  11.10.5 C2N Diagnostics Recent Development
11.11 Cepheid (Danaher)
  11.11.1 Cepheid (Danaher) Company Detail
  11.11.2 Cepheid (Danaher) Business Overview
  11.11.3 Cepheid (Danaher) Proteomic Biomarker Introduction
  11.11.4 Cepheid (Danaher) Revenue in Proteomic Biomarker Business (2018-2023)
  11.11.5 Cepheid (Danaher) Recent Development
11.12 Diadem Diagnostics
  11.12.1 Diadem Diagnostics Company Detail
  11.12.2 Diadem Diagnostics Business Overview
  11.12.3 Diadem Diagnostics Proteomic Biomarker Introduction
  11.12.4 Diadem Diagnostics Revenue in Proteomic Biomarker Business (2018-2023)
  11.12.5 Diadem Diagnostics Recent Development
11.13 Eve Technologies
  11.13.1 Eve Technologies Company Detail
  11.13.2 Eve Technologies Business Overview
  11.13.3 Eve Technologies Proteomic Biomarker Introduction
  11.13.4 Eve Technologies Revenue in Proteomic Biomarker Business (2018-2023)
  11.13.5 Eve Technologies Recent Development
11.14 Fluidic Analytics
  11.14.1 Fluidic Analytics Company Detail
  11.14.2 Fluidic Analytics Business Overview
  11.14.3 Fluidic Analytics Proteomic Biomarker Introduction
  11.14.4 Fluidic Analytics Revenue in Proteomic Biomarker Business (2018-2023)
  11.14.5 Fluidic Analytics Recent Development
11.15 Fujirebio
  11.15.1 Fujirebio Company Detail
  11.15.2 Fujirebio Business Overview
  11.15.3 Fujirebio Proteomic Biomarker Introduction
  11.15.4 Fujirebio Revenue in Proteomic Biomarker Business (2018-2023)
  11.15.5 Fujirebio Recent Development
11.16 Hybrigenics Services
  11.16.1 Hybrigenics Services Company Detail
  11.16.2 Hybrigenics Services Business Overview
  11.16.3 Hybrigenics Services Proteomic Biomarker Introduction
  11.16.4 Hybrigenics Services Revenue in Proteomic Biomarker Business (2018-2023)
  11.16.5 Hybrigenics Services Recent Development
11.17 Luminex Corp (DiaSorin)
  11.17.1 Luminex Corp (DiaSorin) Company Detail
  11.17.2 Luminex Corp (DiaSorin) Business Overview
  11.17.3 Luminex Corp (DiaSorin) Proteomic Biomarker Introduction
  11.17.4 Luminex Corp (DiaSorin) Revenue in Proteomic Biomarker Business (2018-2023)
  11.17.5 Luminex Corp (DiaSorin) Recent Development
11.18 NanoDx
  11.18.1 NanoDx Company Detail
  11.18.2 NanoDx Business Overview
  11.18.3 NanoDx Proteomic Biomarker Introduction
  11.18.4 NanoDx Revenue in Proteomic Biomarker Business (2018-2023)
  11.18.5 NanoDx Recent Development
11.19 Nautilus Biotechnology
  11.19.1 Nautilus Biotechnology Company Detail
  11.19.2 Nautilus Biotechnology Business Overview
  11.19.3 Nautilus Biotechnology Proteomic Biomarker Introduction
  11.19.4 Nautilus Biotechnology Revenue in Proteomic Biomarker Business (2018-2023)
  11.19.5 Nautilus Biotechnology Recent Development
11.20 Nicoya
  11.20.1 Nicoya Company Detail
  11.20.2 Nicoya Business Overview
  11.20.3 Nicoya Proteomic Biomarker Introduction
  11.20.4 Nicoya Revenue in Proteomic Biomarker Business (2018-2023)
  11.20.5 Nicoya Recent Development
11.21 Olink
  11.21.1 Olink Company Detail
  11.21.2 Olink Business Overview
  11.21.3 Olink Proteomic Biomarker Introduction
  11.21.4 Olink Revenue in Proteomic Biomarker Business (2018-2023)
  11.21.5 Olink Recent Development
11.22 Qiagen
  11.22.1 Qiagen Company Detail
  11.22.2 Qiagen Business Overview
  11.22.3 Qiagen Proteomic Biomarker Introduction
  11.22.4 Qiagen Revenue in Proteomic Biomarker Business (2018-2023)
  11.22.5 Qiagen Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Proteomic Biomarker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Mass spectrometry
Table 3. Key Players of Chromatography
Table 4. Key Players of Blotting
Table 5. Key Players of Others
Table 6. Global Proteomic Biomarker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Proteomic Biomarker Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Proteomic Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Proteomic Biomarker Market Share by Region (2018-2023)
Table 10. Global Proteomic Biomarker Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Proteomic Biomarker Market Share by Region (2024-2029)
Table 12. Proteomic Biomarker Market Trends
Table 13. Proteomic Biomarker Market Drivers
Table 14. Proteomic Biomarker Market Challenges
Table 15. Proteomic Biomarker Market Restraints
Table 16. Global Proteomic Biomarker Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Proteomic Biomarker Market Share by Players (2018-2023)
Table 18. Global Top Proteomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomic Biomarker as of 2022)
Table 19. Ranking of Global Top Proteomic Biomarker Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Proteomic Biomarker Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Proteomic Biomarker Product Solution and Service
Table 23. Date of Enter into Proteomic Biomarker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Proteomic Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Proteomic Biomarker Revenue Market Share by Type (2018-2023)
Table 27. Global Proteomic Biomarker Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Proteomic Biomarker Revenue Market Share by Type (2024-2029)
Table 29. Global Proteomic Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Proteomic Biomarker Revenue Market Share by Application (2018-2023)
Table 31. Global Proteomic Biomarker Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Proteomic Biomarker Revenue Market Share by Application (2024-2029)
Table 33. North America Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Proteomic Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Proteomic Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Proteomic Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Proteomic Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Proteomic Biomarker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Proteomic Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Proteomic Biomarker Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Proteomic Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Proteomic Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Proteomic Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Proteomic Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Proteomic Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Proteomic Biomarker Product
Table 51. Abbott Laboratories Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Agilent/Dako Company Detail
Table 54. Agilent/Dako Business Overview
Table 55. Agilent/Dako Proteomic Biomarker Product
Table 56. Agilent/Dako Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 57. Agilent/Dako Recent Development
Table 58. Amprion Company Detail
Table 59. Amprion Business Overview
Table 60. Amprion Proteomic Biomarker Product
Table 61. Amprion Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 62. Amprion Recent Development
Table 63. BasePair Biotechnologies Company Detail
Table 64. BasePair Biotechnologies Business Overview
Table 65. BasePair Biotechnologies Proteomic Biomarker Product
Table 66. BasePair Biotechnologies Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 67. BasePair Biotechnologies Recent Development
Table 68. Beckman Coulter Diagnostics Company Detail
Table 69. Beckman Coulter Diagnostics Business Overview
Table 70. Beckman Coulter Diagnostics Proteomic Biomarker Product
Table 71. Beckman Coulter Diagnostics Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 72. Beckman Coulter Diagnostics Recent Development
Table 73. Becton, Dickinson and Company Company Detail
Table 74. Becton, Dickinson and Company Business Overview
Table 75. Becton, Dickinson and Company Proteomic Biomarker Product
Table 76. Becton, Dickinson and Company Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 77. Becton, Dickinson and Company Recent Development
Table 78. Bio-Rad Laboratories, Inc. Company Detail
Table 79. Bio-Rad Laboratories, Inc. Business Overview
Table 80. Bio-Rad Laboratories, Inc. Proteomic Biomarker Product
Table 81. Bio-Rad Laboratories, Inc. Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 82. Bio-Rad Laboratories, Inc. Recent Development
Table 83. Bio-Techne Company Detail
Table 84. Bio-Techne Business Overview
Table 85. Bio-Techne Proteomic Biomarker Product
Table 86. Bio-Techne Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 87. Bio-Techne Recent Development
Table 88. Bruker Company Detail
Table 89. Bruker Business Overview
Table 90. Bruker Proteomic Biomarker Product
Table 91. Bruker Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 92. Bruker Recent Development
Table 93. C2N Diagnostics Company Detail
Table 94. C2N Diagnostics Business Overview
Table 95. C2N Diagnostics Proteomic Biomarker Product
Table 96. C2N Diagnostics Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 97. C2N Diagnostics Recent Development
Table 98. Cepheid (Danaher) Company Detail
Table 99. Cepheid (Danaher) Business Overview
Table 100. Cepheid (Danaher) Proteomic Biomarker Product
Table 101. Cepheid (Danaher) Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 102. Cepheid (Danaher) Recent Development
Table 103. Diadem Diagnostics Company Detail
Table 104. Diadem Diagnostics Business Overview
Table 105. Diadem Diagnostics Proteomic Biomarker Product
Table 106. Diadem Diagnostics Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 107. Diadem Diagnostics Recent Development
Table 108. Eve Technologies Company Detail
Table 109. Eve Technologies Business Overview
Table 110. Eve Technologies Proteomic Biomarker Product
Table 111. Eve Technologies Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 112. Eve Technologies Recent Development
Table 113. Fluidic Analytics Company Detail
Table 114. Fluidic Analytics Business Overview
Table 115. Fluidic Analytics Proteomic Biomarker Product
Table 116. Fluidic Analytics Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 117. Fluidic Analytics Recent Development
Table 118. Fujirebio Company Detail
Table 119. Fujirebio Business Overview
Table 120. Fujirebio Proteomic Biomarker Product
Table 121. Fujirebio Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 122. Fujirebio Recent Development
Table 123. Hybrigenics Services Company Detail
Table 124. Hybrigenics Services Business Overview
Table 125. Hybrigenics Services Proteomic Biomarker Product
Table 126. Hybrigenics Services Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 127. Hybrigenics Services Recent Development
Table 128. Luminex Corp (DiaSorin) Company Detail
Table 129. Luminex Corp (DiaSorin) Business Overview
Table 130. Luminex Corp (DiaSorin) Proteomic Biomarker Product
Table 131. Luminex Corp (DiaSorin) Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 132. Luminex Corp (DiaSorin) Recent Development
Table 133. NanoDx Company Detail
Table 134. NanoDx Business Overview
Table 135. NanoDx Proteomic Biomarker Product
Table 136. NanoDx Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 137. NanoDx Recent Development
Table 138. Nautilus Biotechnology Company Detail
Table 139. Nautilus Biotechnology Business Overview
Table 140. Nautilus Biotechnology Proteomic Biomarker Product
Table 141. Nautilus Biotechnology Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 142. Nautilus Biotechnology Recent Development
Table 143. Nicoya Company Detail
Table 144. Nicoya Business Overview
Table 145. Nicoya Proteomic Biomarker Product
Table 146. Nicoya Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 147. Nicoya Recent Development
Table 148. Olink Company Detail
Table 149. Olink Business Overview
Table 150. Olink Proteomic Biomarker Product
Table 151. Olink Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 152. Olink Recent Development
Table 153. Qiagen Company Detail
Table 154. Qiagen Business Overview
Table 155. Qiagen Proteomic Biomarker Product
Table 156. Qiagen Revenue in Proteomic Biomarker Business (2018-2023) & (US$ Million)
Table 157. Qiagen Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Proteomic Biomarker Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Proteomic Biomarker Market Share by Type: 2022 VS 2029
Figure 3. Mass spectrometry Features
Figure 4. Chromatography Features
Figure 5. Blotting Features
Figure 6. Others Features
Figure 7. Global Proteomic Biomarker Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Proteomic Biomarker Market Share by Application: 2022 VS 2029
Figure 9. Bio Industry Case Studies
Figure 10. Medical Industry Case Studies
Figure 11. Others Case Studies
Figure 12. Proteomic Biomarker Report Years Considered
Figure 13. Global Proteomic Biomarker Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Proteomic Biomarker Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Proteomic Biomarker Market Share by Region: 2022 VS 2029
Figure 16. Global Proteomic Biomarker Market Share by Players in 2022
Figure 17. Global Top Proteomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proteomic Biomarker as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Proteomic Biomarker Revenue in 2022
Figure 19. North America Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Proteomic Biomarker Market Share by Country (2018-2029)
Figure 21. United States Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Proteomic Biomarker Market Share by Country (2018-2029)
Figure 25. Germany Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Proteomic Biomarker Market Share by Region (2018-2029)
Figure 33. China Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Proteomic Biomarker Market Share by Country (2018-2029)
Figure 41. Mexico Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Proteomic Biomarker Market Share by Country (2018-2029)
Figure 45. Turkey Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Proteomic Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 48. Agilent/Dako Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 49. Amprion Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 50. BasePair Biotechnologies Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 51. Beckman Coulter Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 53. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 54. Bio-Techne Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 55. Bruker Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 56. C2N Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 57. Cepheid (Danaher) Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 58. Diadem Diagnostics Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 59. Eve Technologies Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 60. Fluidic Analytics Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 61. Fujirebio Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 62. Hybrigenics Services Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 63. Luminex Corp (DiaSorin) Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 64. NanoDx Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 65. Nautilus Biotechnology Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 66. Nicoya Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 67. Olink Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 68. Qiagen Revenue Growth Rate in Proteomic Biomarker Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed